Batinic-Haberle, I., Tovmasyan, A., Veade, A., Spasojevic, I., Reihani, S., & Secord, A. (2018). Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy. In Free Radical Biology and Medicine (Vol. 128, pp. S74–S75). Elsevier BV. https://doi.org/10.1016/j.freeradbiomed.2018.10.162

Batinic-Haberle, Ines, Artak Tovmasyan, Ashley Veade, Ivan Spasojevic, Shara Reihani, and Angeles Secord. “Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy.” In Free Radical Biology and Medicine, 128:S74–75. Elsevier BV, 2018. https://doi.org/10.1016/j.freeradbiomed.2018.10.162.

Batinic-Haberle I, Tovmasyan A, Veade A, Spasojevic I, Reihani S, Secord A. Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy. In: Free Radical Biology and Medicine. Elsevier BV; 2018. p. S74–5.

Batinic-Haberle, Ines, et al. “Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy.” Free Radical Biology and Medicine, vol. 128, Elsevier BV, 2018, pp. S74–75. Crossref, doi:10.1016/j.freeradbiomed.2018.10.162.

Batinic-Haberle I, Tovmasyan A, Veade A, Spasojevic I, Reihani S, Secord A. Mn porphyrin/ascorbate sensitizes serous epithelial ovarian cancer to chemotherapy. Free Radical Biology and Medicine. Elsevier BV; 2018. p. S74–S75.